Bone fracture

Conventional Theories of Photoaging and Skin Cancer Challenged by Scientist, Dr. Win L. Chiou

Retrieved on: 
Venerdì, Febbraio 17, 2023
DNA, Intrinsic factor, Human, Water, Skin cancer, Harvard University, Immunity, Publication, BCC, Vitamin D, Kinetics, Skin, Erythema, Criticism of the Food and Drug Administration, Bone fracture, Carcinoma, Sun, Melanoma, Wind, Sunlight, Ageing, Nutrient, University, Food, Health, UV, Risk, SPF, Beauty, Radiation, Stroke, Collagen, Sunburn, FDA, Research, SCC, University of Illinois Urbana-Champaign, Enzyme, Elastin, Cardiac output, Hyaluronic acid, JAMA Dermatology, Dietary supplement, Chiou Lien-hui, Dermatology

Dr. Chiou, renowned retired professor from University of Illinois at Chicago with over 200 publications, 6 patents, about 100 invited presentations, and served on editorial boards of 9 journals, and as FDA/law-firm consultant, has published numerous articles challenging conventional concepts on skin aging and skin cancer.

Key Points: 
  • Dr. Chiou, renowned retired professor from University of Illinois at Chicago with over 200 publications, 6 patents, about 100 invited presentations, and served on editorial boards of 9 journals, and as FDA/law-firm consultant, has published numerous articles challenging conventional concepts on skin aging and skin cancer.
  • Shuster's work was recently supported by Chiou's exponential kinetic analysis of their data that also clearly contradicted conventional accelerated aging theory.
  • Chiou's articles in 2022 were published in Journal of Dermatology Research and have received over 200,000 views to date.
  • Win Chiou, President of Chiou Consulting Inc, can be reached at 630-789-9081 or [email protected] .

New CDAHK Study Finds Severe Adverse Events Associated with Chiropractic Treatment Are Very Rare

Retrieved on: 
Venerdì, Gennaio 27, 2023
Linda, Spine, Data, Bone fracture, Osteoporosis, Scientific Reports, School, Death, Metropolitan University, Safety, University Hospitals Cleveland Medical Center, Risk, Common Terminology Criteria for Adverse Events, Neck pain, Woman, CTCAE, Joint, Patient, Engineering, Roger Hawkins (drummer), Georgetown University School of Nursing and Health Studies, Niazi, Incidence, Healthcare, Medical device, Pharmaceutical industry, Nursing, Chiropractic

Severe adverse events associated with chiropractic treatment were found to be very rare.

Key Points: 
  • Severe adverse events associated with chiropractic treatment were found to be very rare.
  • Researchers from the Chiropractic Doctors Association of Hong Kong found that two patients experienced severe adverse events during or after their chiropractic spinal manipulation.
  • The incidence of severe adverse events was 0.21 per 100,000 treatments, which suggested that such complications were reassuringly very rare.
  • "The incidence of severe adverse events was extremely low," said Dr. Eric Chun-Pu Chu, lead author and Chairman of CDAHK.

Byron Wien and Joe Zidle Announce the Ten Surprises of 2023

Retrieved on: 
Mercoledì, Gennaio 4, 2023
Personal Finance, Finance, Banking, Professional Services, Asset Management, Morgan Stanley, Federal Reserve, Apple, Climate, Samsung, Ten, Fed, Funeral home, Blackstone, Disease, Personal consumption expenditures price index, Growth, Modern Monetary Theory, Bone fracture, West Texas Intermediate, Carbon, Renewable energy

Byron R. Wien, Vice Chairman together with Joe Zidle, Chief Investment Strategist in the Private Wealth Solutions group at Blackstone, today issued their list of the Ten Surprises of 2023.

Key Points: 
  • Byron R. Wien, Vice Chairman together with Joe Zidle, Chief Investment Strategist in the Private Wealth Solutions group at Blackstone, today issued their list of the Ten Surprises of 2023.
  • This is the 38th year Byron has given his views on a number of economic, financial market and political surprises for the coming year.
  • In 2018, Joe Zidle joined Byron Wien in the development of the Ten Surprises.
  • Byron and Joe’s Ten Surprises of 2023 are as follows:
    Multiple candidates on both sides of the aisle organize campaigns to secure their party’s presidential nomination.

Radius Health's TYMLOS® (abaloparatide) Receives U.S. FDA Approval as a Treatment to Increase Bone Density in Men with Osteoporosis at High Risk for Fracture

Retrieved on: 
Martedì, Dicembre 20, 2022
Bone fracture, Patient, History, Abaloparatide, Food, BMD, FDA, Safety, Bone density, Radius, Osteoporosis, Fracture, Regulation of tobacco by the U.S. Food and Drug Administration, Dietary supplement

Additionally, while the overall prevalence of fragility fractures is higher in women, men generally have higher rates of fracture-related mortality.

Key Points: 
  • Additionally, while the overall prevalence of fragility fractures is higher in women, men generally have higher rates of fracture-related mortality.
  • "2,3,4
    "TYMLOS has been helping postmenopausal women with osteoporosis at high risk for fracture for over five years.
  • "Radius stands behind our commitment to the bone health community and with this approval, men with osteoporosis at high risk for fracture will have an additional important treatment option," said Scott Briggs, Chief Executive Officer at Radius.
  • ©2022 Radius Health, Inc. TYMLOS is a registered trademark of Radius Health Inc.
    View original content to download multimedia: https://www.prnewswire.com/news-releases/radius-healths-tymlos-abalopara...

Building Homes for Heroes expands benefits program, makes first contribution to family of FDNY firefighter

Retrieved on: 
Lunedì, Dicembre 19, 2022
Father's Day, Bone fracture, Biltmore Estate, Courage, Charity, Family, Heroes, Water, Building Homes from What We've Known, FDNY, Fire, Police, NYPD, Charity Navigator, Veteran, Firefighter, Hospital

Casey had planned the trip to celebrate what would have been his 46th birthday on Father's Day.

Key Points: 
  • Casey had planned the trip to celebrate what would have been his 46th birthday on Father's Day.
  • This outreach from the Building Homes for Heroes team not only honors my late husband's service, but it keeps us in our home so we can focus on healing."
  • "It's extra special for our organization, based in Island Park, to help a family here in our own coastal community."
  • For Building Homes for Heroes, the mission expansion marks a pivotal point in its charitable efforts.

TAG Oil Provides Operations Updates

Retrieved on: 
Giovedì, Dicembre 15, 2022
Well, BED, Hydrocarbon, API, TAG, Bone fracture, Natural gas, TAG Oil, News, Permeability, ARF, TSX, Oil, Risk management

VANCOUVER, BC, Dec. 15, 2022 /PRNewswire/ - TAG Oil Ltd. (TSXV: TAO) (OTCQX: TAOIF)("TAG Oil" or the "Company") is pleased to provide an operations update as the Company initiates Phase 1 of its strategic development program of the unconventional Abu Roash "F" ("ARF") reservoir in the Badr Oil Field ("BED-1") over the first half of 2023, consisting of the following:

Key Points: 
  • VANCOUVER, BC, Dec. 15, 2022 /PRNewswire/ - TAG Oil Ltd. (TSXV: TAO) (OTCQX: TAOIF)("TAG Oil" or the "Company") is pleased to provide an operations update as the Company initiates Phase 1 of its strategic development program of the unconventional Abu Roash "F" ("ARF") reservoir in the Badr Oil Field ("BED-1") over the first half of 2023, consisting of the following:
    First Well Re-Completion: TAG Oil has chosen the BED 1-7 vertical well for its first re-completion and evaluation operations in BED-1.
  • Services and equipment for these operations are being secured, which TAG Oil has scheduled to be in place for operations to commence in mid-January 2023.
  • TAG Oil ( http://www.tagoil.com/ ) is a Canadian based international oil and gas exploration company with a focus on operations and opportunities in the Middle East and North Africa.
  • Statements contained in this news release that are not historical facts are forward-looking statements that involve various risks and uncertainty affecting the business of TAG Oil.

Janssen Submits Biologics License Application to U.S. FDA for Talquetamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

Retrieved on: 
Venerdì, Dicembre 9, 2022
Heart, Multiple myeloma, CD3, Society, Johnson & Johnson, Disease, Patient, Behavior, Metabolism, Biologics license application, Lymphatic system, Bone fracture, Royal commission, GPRC5D, American Cancer Society, Pain, Fatigue, Bone marrow, B cell, Pulmonary hypertension, Abstract, Security (finance), Food, Regulation of tobacco by the U.S. Food and Drug Administration, Science, Janssen Pharmaceuticals, RRMM, Breakthrough therapy, Risk, ASH, BLA, Orphan drug, Annual report, Research, FDA, Medicine, Blood, European Commission, Medication, Janssen, Vaccine, Pharmaceutical industry, Fine chemical, Oncology, Hematology, Neuroscience

RARITAN, N.J., Dec. 9, 2022 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for talquetamab forthetreatment of patients with relapsed or refractory multiple myeloma.

Key Points: 
  • RARITAN, N.J., Dec. 9, 2022 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for talquetamab forthetreatment of patients with relapsed or refractory multiple myeloma.
  • We look forward to working closely with the FDA in their review of the talquetamab submission."
  • In May 2021 and August 2021, talquetamab received an Orphan Drug designation for the treatment of multiple myeloma by the U.S. FDA and the European Commission, respectively.
  • Janssen Research & Development, LLC and Janssen Biotech, Inc. are part of the Janssen Pharmaceutical Companies of Johnson & Johnson.

SENATOR CAPITO SELECTED AS CONGRESSIONAL BONE HEALTH CHAMPION AWARD WINNER FOR "OUTSTANDING LEADERSHIP, ADVOCACY AND COMMITMENT"

Retrieved on: 
Giovedì, Dicembre 8, 2022
Conditional sentence, Life, Diagnosis, Tax Parity for Health Plan Beneficiaries Act, Bone health, Fracture, Research, Breast cancer, Disease, Bone fracture, Woman, Overalls, Quality of life, Bone density, Education, Milliman, Health, Congress, Osteoporosis, Stroke, Legislation, Medicare, Risk, Dietary supplement

ARLINGTON, Va., Dec. 8, 2022 /PRNewswire/ -- Senator Shelley Moore Capito (R-West Virginia) has been selected as a 2022 recipient of the Congressional Bone Health Champion award by the Bone Health and Osteoporosis Foundation (BHOF).

Key Points: 
  • ARLINGTON, Va., Dec. 8, 2022 /PRNewswire/ -- Senator Shelley Moore Capito (R-West Virginia) has been selected as a 2022 recipient of the Congressional Bone Health Champion award by the Bone Health and Osteoporosis Foundation (BHOF).
  • The award annually recognizes Members of Congress who have demonstrated outstanding leadership, advocacy, and commitment to protect and improve the bone health of all Americans.
  • Congress needs to prioritize bone health on our nation's healthcare agenda, and pass legislation to improve bone health screening.
  • Established in 1984, BHOF is the nation'slargest health organization dedicated to osteoporosis and bone health.

REP. LINDA SÁNCHEZ SELECTED AS CONGRESSIONAL BONE HEALTH CHAMPION AWARD WINNER FOR "OUTSTANDING LEADERSHIP, ADVOCACY AND COMMITMENT"

Retrieved on: 
Mercoledì, Dicembre 7, 2022
Linda, Conditional sentence, Life, Diagnosis, Tax Parity for Health Plan Beneficiaries Act, Bone health, Fracture, Research, Breast cancer, Disease, Bone fracture, Woman, Quality of life, Bone density, Education, Milliman, Health, Congress, Osteoporosis, Stroke, Legislation, Medicare, Risk, Dietary supplement

ARLINGTON, Va., Dec. 7, 2022 /PRNewswire/ -- Representative Linda Snchez (D-California) has been selected as a 2022 recipient of the Congressional Bone Health Champion award by the Bone Health and Osteoporosis Foundation (BHOF).

Key Points: 
  • ARLINGTON, Va., Dec. 7, 2022 /PRNewswire/ -- Representative Linda Snchez (D-California) has been selected as a 2022 recipient of the Congressional Bone Health Champion award by the Bone Health and Osteoporosis Foundation (BHOF).
  • The award annually recognizes Members of Congress who have demonstrated outstanding leadership, advocacy, and commitment to protect and improve the bone health of all Americans.
  • Congress needs to prioritize bone health on our nation's healthcare agenda, and pass legislation to improve bone health screening.
  • Established in 1984, BHOF is the nation'slargest health organization dedicated to osteoporosis and bone health.

REP. BURGESS SELECTED AS CONGRESSIONAL BONE HEALTH CHAMPION AWARD WINNER FOR "OUTSTANDING LEADERSHIP, ADVOCACY AND COMMITMENT"

Retrieved on: 
Giovedì, Dicembre 1, 2022
Bone density, Bone health, Milliman, Diagnosis, Stroke, Conditional sentence, Osteoporosis, Risk, Life, Overalls, Education, Legislation, Fracture, Bone fracture, Disease, Medicare, Health, Research, Congress, Tax Parity for Health Plan Beneficiaries Act, Quality of life, Woman, Breast cancer, Dietary supplement

(R-Texas) has been selected as a 2022 recipient of the Congressional Bone Health Champion award by the Bone Health and Osteoporosis Foundation (BHOF).

Key Points: 
  • (R-Texas) has been selected as a 2022 recipient of the Congressional Bone Health Champion award by the Bone Health and Osteoporosis Foundation (BHOF).
  • The award annually recognizes Members of Congress who have demonstrated outstanding leadership, advocacy, and commitment to protect and improve the bone health of all Americans.
  • Congress needs to prioritize bone health on our nation's healthcare agenda, and pass legislation to improve bone health screening.
  • Established in 1984, BHOF is the nation'slargest health organization dedicated to osteoporosis and bone health.